Actavis PLC (NYSE:ACT)

289.78
Delayed Data
As of Feb 26
 -0.62 / -0.21%
Today’s Change
184.71
Today|||52-Week Range
296.77
+12.58%
Year-to-Date

Today’s Trading

Previous close290.40
Today’s open290.25
Day’s range-- - --
Volume3,206,511
Average volume (3 months)2,766,870
Market cap$77.3B
Dividend yield--
Data as of 02/26/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+22.60%
Earnings growth (next 5 years)+20.70%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.33-0.47%
ABTAbbott Laboratories+0.21+0.44%
AGNAllergan-0.08-0.03%
AZNAstraZeneca-0.66-0.95%
Data as of 02/26/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$4.07
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account